Risk of relapses during pregnancy among multiple sclerosis patients
ConclusionsRelapse rate during pregnancy was higher than previous studies conducted in patients on platform therapies or untreated. Longer washout period prior to conception was associated with increased relapses especially in fingolimod and natalizumab treated patients.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
More News: Gilenya | Kuwait Health | Lebanon Health | Middle East Health | Multiple Sclerosis | Neurology | Pregnancy | Study | Tysabri | Women